Skip to content

Enovis ENOV Accounts Receivable

Accounts Receivable at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$17.72B+10.6%
Stryker logo
StrykerSYK
$3.57B-9.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.73B+12.7%
ESAB logo
ESABESAB
$488.46M+17.8%
Vericel logo
VericelVCEL
$72.38M+36.8%
Globus Medical logo
Globus MedicalGMED
$686.43M+28.3%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-40.2%
Enterprise value$2.55B-25.8%
P/S0.5×-0.4×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's accounts receivable?
Enovis (ENOV) reported accounts receivable of $444.21M in Q1 2026.
How has Enovis's accounts receivable changed year-over-year?
Enovis's accounts receivable increased by 2.0% year-over-year, from $435.62M to $444.21M.
What is the long-term trend for Enovis's accounts receivable?
Over 5 years (2020 to 2025), Enovis's accounts receivable has grown at a -3.1% compound annual growth rate (CAGR), from $517.01M to $442.79M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.